BASF biological method of acrylamide production plant in Nanjing, China built

BASF’s first set of bio-process acrylamide (BIOACM) devices in Asia Pacific, efficient and environmentally friendly production

Bacillus thuringiensis

 

October 23, 2017, BASF in China’s Nanjing Chemical Industry Park, an industry-leading production plant of bio-process acrylamide.

 

By investing in this wholly-owned production facility, BASF will further improve the production capacity of high quality polyacrylamide to ensure a stable supply to customers in the region, especially in China. The device can produce more than 50,000 tonnes of acrylamide per year.

 

Acrylamide is used in the production of water-soluble flocculants, so that the improvement of wastewater treatment, papermaking, mineral processing and oil recovery is more efficient and more resource-saving. Located in the center of the Water Treatment and paper industry in the Asia-Pacific region, the commissioning of the new installation will further consolidate BASF’s dominance in the region and increase the cost competitiveness of the product supply to meet the growing demand of the high water industry.

 

“We are delighted to be with our customers and government representatives to celebrate the commissioning of the Nanjing BIOACM plant,” said Andreastuerk, senior vice president of the BASF paper and Water Treatment Chemicals business unit. This investment fully embodies BASF’s strategic commitment to the polyacrylamide industry, and we will continue to work to meet the growing business needs of China and the world’s high water industry. ”

 

Since 2014, BASF has started producing bio-Virginia State acrylamide in the United States, and in 2016 a new bio-method of acrylamide was put into operation in Bradford, UK. After the successful commissioning of the Nanjing Project, BASF has three of the most advanced production devices in the world’s major markets.
Chitosan oligosaccharide
“The completion of the BIOACM device is an important milestone in the history of the development of BASF’s Nanjing base, which lays a foundation for future expansion.” The new Polyacrylamide production line is under construction and is expected to be operational in 2018. By investing in the upstream and downstream production units, we have further consolidated BASF’s position as the preferred partner in papermaking and water treatment industry. ”

 

Compared with the traditional catalysis technology of high pressure and energy-consuming copper, the waste produced by enzymatic process is greatly reduced. The process can be carried out at room temperature and under normal atmospheric conditions, which will help conserve energy and improve environmental compatibility. At the same time, there are fewer byproducts.

 

“The Nanjing BIOACM device is built in strict accordance with BASF’s high standards of global security and environment,” said Mollison, global senior vice-president of BASF, who is responsible for operations and base management in Greater China. We provide special training to our employees and safety specialists to ensure that we meet the same safety standards as all other production facilities. ”

Sodium Molybdate